Save the date! Join your colleagues from around the world to network and discuss challenges and opportunities for the global generics and biosimilars industries. For the first time since 2014, IGBA's Annual Conference is being held in the United States, in conjunction with AAM's Access! 2023 Annual Meeting. This event will offer a unique opportunity to hear from leading global stakeholders, industry leaders and other experts offering their views and analysis of the most pressing policy questions influencing patient access to generic and biosimilar medicines in countries around the world. Register Today!